Identity and synonyms
Catalog label is recorded; analytical identity and equivalence are not established.
Peptide or peptide-related · Peptide or peptide derivative
Detailed molecular class: Peptide or peptide-derivative label; see identity
Supplied sequence or chemical reference
Mechanism
Tetrapeptide bioregulator studied in pancreatic function; the name does not identify an authorized antidiabetic therapy.
Evidence and critical reading
Reported scientific and empirical uses
Reported glycemic control
Promoted for glucose/pancreatic aging; distinguish primate studies from human trials.
Human evidence
The 2017 study included nine old female rhesus monkeys: five received Pancragen/four glimepiride. Animal metabolic changes establish neither human efficacy nor a human dose.
Preclinical evidence
Do not equate mechanism, cell culture or animal work with a clinical outcome. The specific level is detailed in the evidence assessment.
Critical reading and limitations
The 2017 study included nine old female rhesus monkeys: five received Pancragen/four glimepiride. Animal metabolic changes establish neither human efficacy nor a human dose.
The 2017 study included nine old female rhesus monkeys: five received Pancragen/four glimepiride. Animal metabolic changes establish neither human efficacy nor a human dose.
Source-specific regimens
Descriptive source observations, not individual recommendations.
Regulatory product labeling
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Human-study exposure
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Empirical handbook
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Regulation and safety
Jurisdiction-specific regulatory context
This record does not verify FDA/EMA authorization of the commercial identity. Where a specific medicine/product exists, jurisdiction/indication are detailed in cited sources; they do not transfer to supplier material.
Adverse effects and unknowns
Do not infer clinical safety from nutrients or an animal antidiabetic comparison. Combination with glucose-lowering medicines remains uncharacterized.
Contraindications
A complete list must match the exact authorized product. For experimental materials without verified human labeling, a complete contraindication set is not established here. No list does not mean safety.
Interactions
Separate documented interaction, pharmacologic plausibility and unknown interaction. Absence of a blend trial does not establish compatibility.
Studies and trials
Selected studies
PMID28509500 · Animal experiment
Old female rhesus monkeys: 5 Pancragen, 4 glimepiride.
Animal experiment.
Glucose-tolerance/hormone changes.
Nonhuman primate; no human regimen/established antidiabetic efficacy.
n = 9
Trials attributed in the package
No trials are attributed in this record.
Trial registration does not establish efficacy or validate commercial material.
Query candidates; attribution pending
Pancragen · 0 unfiltered query results, not authenticated trials
Query verification: October 16, 2026
Exact phrase intervention query; first three most recently updated records, not exhaustive. Aliases may be missed and heterogeneous products may appear. The total is the unfiltered registry query count, not authenticated trials. Source-integrity holds are excluded from ordinary listings.
View trial registry querySource issues and references
References include queries and bibliographic handbook attributions; not all are clinical studies. Human review remains pending.
- PMID25946840
[Impact of tetrapeptide pancragen on endocrine function of the pancreas in old monkeys].
Goncharova ND, Ivanova LG, Oganian TÉ, Vengerin AA, Khavinson VKh.
October 16, 2026
- PMID28509500
Goncharova ND, Ivanova LG, Oganyan TE, Vengerin AA, Khavinson VK.
October 16, 2026
- SEARCH-PUBMED-pancragen
PubMed/MED targeted search: TITLE_ABS:pancragen
October 16, 2026